IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancer
IFITM3-MET相互作用通过激活AKT通路驱动EGFR突变型非小细胞肺癌产生奥希替尼耐药性
期刊:Mol Cancer
影响因子:27.700
doi:10.1186/s12943-025-02493-6.
Ritsu Ibusuki,Eiji Iwama,Atsushi Shimauchi,Hiromu Kawano,Shun Mizusaki,Satoshi Nakamura,Yui Miyazaki,Yu Inutsuka,Mikiko Hashisako,Taishi Harada,Yuko Tsuchiya-Kawano,Hirono Tsutsumi,Takayuki Nakanishi,Noriaki Nakagaki,Yuichiro Koga,Shinichi Kimura,Shun Mashimoto,Daisuke Shibahara,Kohei Otsubo,Yasuto Yoneshima,Kentaro Tanaka,Yoshinao Oda,Isamu Okamoto
肺癌
细胞生物学
信号转导
肿瘤
EGF
AKT
EGFR
MET
PI3K/Akt